A potential abstract/article for publication in E-Letters should meet the following guidelines:
The article should be written for technical professionals on topics of special interest to subscribers of the particular COP. The editorial objective is to provide practical application-related articles on timely subjects of interest to COP members.
Commercialism in E-Letters is strictly prohibited. Commercialism is deemed to be the inclusion of visual, written, or verbal references to any specific company and/or product for its promotion or commercial advantage. Articles that promote a specific product or company will not be accepted.
All articles are reviewed for content, quality, and interest to our readership by ISPE Marketing and Communications staff. Due to the editorial "focus" approach applied to the e-letters, some articles may be held for appropriate editions. Articles written by ISPE or COP members with unique content may be subject to "members only".
The International Society for Pharmaceutical Engineering (ISPE) retains full editorial control of the contents of E-Letters, and is therefore authorized to revise and delete copy as appropriate.
The author is responsible for the accuracy and correctness of all statements contained in the content Content written by ISPE staff shall be reviewed by COP liaisons.
Content Submission Information
Several examples are shown:
FDA Office of Pharmaceutical Quality Initiatives & 2016 Priorities
Friday, 24 Jun 2016 12.06
Interdisciplinary Perspectives on Key Pharma Industry Trends
Thursday, 23 Jun 2016 15.06
Endless Opportunities to Expand Your Knowledge & Network
Wednesday, 22 Jun 2016 12.06